Small-molecule therapeutics that target RNA processing pathways.
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
25
NCT04675996
First-in-Human Study of INT-1B3 in Patients With Advanced Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Dec 18, 2020
Completion: Mar 24, 2023
Loading map...